Heart failure stem cell trial pulled before it began
NCT ID NCT06840275
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial aimed to test whether infusions of stem cells from donated fat tissue could improve heart function in people recently diagnosed with non-ischemic heart failure. Participants would have received two infusions a month apart. However, the study was withdrawn before enrolling anyone, so no data was collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- allogeneic adipose tissue-derived mesenchymal stem cells (C2C_ASC110)
- What this could lead to
- If this approach had worked, it could have pointed toward a new treatment to improve heart function in people with heart failure.
- What could go wrong
- This trial was withdrawn before any participants were enrolled, so no results are available. The approach was still experimental and early-stage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ISCHEMIC HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cardiology Stem Cell Centre, Department of Cardiology, The Heart Centre, Rigshospitalet, University of Copenhagen, Denmark
Copenhagen, 2100, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.